Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$10.41−1.33 (-11.33%)
Close on Nov 18, 2026Market cap $70.68MP/E –Yield –
Eloxx Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Eloxx Pharmaceuticals's operating cash flow for the twelve months ending Dec 31, 2023 was -$14.34M. For fiscal 2025 it was -$6.33M. The highest annual figure on record is -$3.68M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.33M | – |
| FY2024 | Dec 31, 2024 | -$4.72M | – |
| FY2023 | Dec 31, 2023 | -$14.34M | – |
| FY2022 | Dec 31, 2022 | -$31.85M | – |
| FY2021 | Dec 31, 2021 | -$35.00M | – |
| FY2020 | Dec 31, 2020 | -$28.17M | – |
| FY2019 | Dec 31, 2019 | -$39.39M | – |
| FY2018 | Dec 31, 2018 | -$31.37M | – |
| FY2016 | Jun 30, 2016 | -$3.68M | – |
| FY2015 | Jun 30, 2015 | -$7.34M | – |
| FY2014 | Jun 30, 2014 | -$4.87M | – |
| FY2013 | Jun 30, 2013 | -$3.90M | – |
| FY2012 | Jun 30, 2012 | -$4.39M | – |
| FY2011 | Jun 30, 2011 | -$5.39M | – |
| FY2010 | Jun 30, 2010 | -$4.74M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$4.79M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$5.45M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$1.75M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $1.20M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$2.01M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$3.45M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$2.07M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$6.81M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$5.66M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$6.95M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$9.75M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$9.49M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$9.93M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$7.59M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$9.80M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$7.69M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$4.67M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$5.26M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$6.32M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$11.92M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$9.26M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$11.32M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$9.62M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$9.19M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$9.06M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$8.10M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$8.51M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$5.70M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$714.79K | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$840.98K | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$988.30K | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$1.13M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$2.42M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$1.45M | – |
| Q2 FY2015CQ4 2014 | Dec 31, 2014 | -$1.53M | – |
| Q1 FY2015CQ3 2014 | Sep 30, 2014 | -$1.94M | – |
| Q4 FY2014CQ2 2014 | Jun 30, 2014 | -$1.22M | – |
| Q3 FY2014CQ1 2014 | Mar 31, 2014 | -$1.56M | – |
See a number that looks wrong?